PTC
WST icon

Private Trust Company’s West Pharmaceutical WST Stock Holding History

Private Trust Company’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42K Buy
117
+14
+14% +$4.28K ﹤0.01% 1455
2026
Q1 		$25.8K Buy
103
+3
+3% +$746 ﹤0.01% 1578
2025
Q4 		$27.5K Buy
100
+61
+156% +$16.7K ﹤0.01% 1521
2025
Q3 		$10.2K Sell
39
-81
-68% -$19.7K ﹤0.01% 1897
2025
Q2 		$26.3K Sell
120
-56
-32% -$12K ﹤0.01% 1461
2025
Q1 		$39.4K Buy
176
+40
+29% +$11K ﹤0.01% 1287
2024
Q4 		$44.5K Buy
136
+79
+139% +$24.9K ﹤0.01% 1210
2024
Q3 		$17.1K Sell
57
-72
-56% -$22.1K ﹤0.01% 1527
2024
Q2 		$42.5K Buy
129
+8
+7% +$2.83K ﹤0.01% 1174
2024
Q1 		$47.9K Buy
121
+4
+3% +$1.48K 0.01% 1118
2023
Q4 		$41.2K Hold
117
– – ﹤0.01% 1128
2023
Q3 		$43.9K Sell
117
-18
-13% -$6.96K 0.01% 1065
2023
Q2 		$51.6K Sell
135
-9
-6% -$3.21K 0.01% 1019
2023
Q1 		$49.9K Sell
144
-30
-17% -$8.77K 0.01% 997
2022
Q4 		$41K Buy
174
+9
+5% +$2.13K 0.01% 1036
2022
Q3 		$41K Buy
165
+109
+195% +$33.2K 0.01% 959
2022
Q2 		$17K Buy
+56
New +$18.2K ﹤0.01% 1299
2014
Q4 		– Sell
-110
Closed -$5K – 1192
2014
Q3 		$5K Hold
110
– – ﹤0.01% 1326
2014
Q2 		$5K Hold
110
– – ﹤0.01% 1309
2014
Q1 		$5K Hold
110
– – ﹤0.01% 1199
2013
Q4 		$5K Hold
110
– – ﹤0.01% 1180
2013
Q3 		$5K Hold
110
– – ﹤0.01% 1145
2013
Q2 		$4K Buy
+110
New +$3.62K ﹤0.01% 1153

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Private Trust Company's WST Position: Q2 2026 in Review

Private Trust Company increased its West Pharmaceutical (WST) stake by 14% in Q2 2026, buying an estimated $4.28K and bringing the position to 117 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #1455.

Private Trust Company first reported a position in WST in Q2 2013 and has held it in 23 quarters since. The position peaked at $51.6K in Q2 2023. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Private Trust Company held 117 shares of West Pharmaceutical worth $42K as of Q2 2026.
  • Private Trust Company bought 14 West Pharmaceutical shares in Q2 2026, an estimated $4.28K.
  • West Pharmaceutical made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #1455 holding.
  • Private Trust Company first reported a position in West Pharmaceutical in Q2 2013 and has held it in 23 quarters since.
  • Private Trust Company's West Pharmaceutical position peaked at $51.6K in Q2 2023.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.